Package 68788-8454-3

Brand: amlodipine and benazepril hydrochloride

Generic: amlodipine and benazepril hydrochloride
NDC Package

Package Facts

Identity

Package NDC 68788-8454-3
Digits Only 6878884543
Product NDC 68788-8454
Description

30 CAPSULE in 1 BOTTLE (68788-8454-3)

Marketing

Marketing Status
Marketed Since 2023-06-02
Brand amlodipine and benazepril hydrochloride
Generic amlodipine and benazepril hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ee887783-3d4a-4eb5-af46-ca1807e5d7d3", "openfda": {"unii": ["864V2Q084H", "N1SN99T69T"], "rxcui": ["898342"], "spl_set_id": ["b25681a9-7b0e-40f9-844e-ec4842e3713c"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (68788-8454-3)", "package_ndc": "68788-8454-3", "marketing_start_date": "20230602"}], "brand_name": "Amlodipine and Benazepril Hydrochloride", "product_id": "68788-8454_ee887783-3d4a-4eb5-af46-ca1807e5d7d3", "dosage_form": "CAPSULE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "68788-8454", "generic_name": "Amlodipine and Benazepril Hydrochloride", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine and Benazepril Hydrochloride", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "10 mg/1"}, {"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "20 mg/1"}], "application_number": "ANDA202239", "marketing_category": "ANDA", "marketing_start_date": "20230602", "listing_expiration_date": "20271231"}